Since boththe hypoglycemia symptom scores and counterregulatory responses evoked by icodec wassimilar to IGlar U100, it appears likely that practices around hypoglycemia recognitionand acute treatment that are currently in place for once-daily insulin analogues couldalso be applicable to once-weekly insulin treatment. This evidence concerns the gene INS and Hypoglycemia.